Home›Companies›Belenos Biosciences

Belenos Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Jul 17, 2024·Suggest an edit

About Belenos Biosciences

Belenos Biosciences is a private company based in New York, New York, incorporated in 2024 in Delaware. It has reported $48,000,000 raised in one offering on Form D since July 2024. Its chief executive is StJohn McGrath.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 8, 2024Jul 17, 2024$48,000,000of $55.0M target2$24.0MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Belenos Biosciences's Form D filed Jul 17, 2024.

BC
Bo Chen
Director
CG
Carl Gordon
Director
TD
Tania Dimitrova
Executive officer
DW
David Wang
Director
MD
Megan Dow
Executive officer
SM
StJohn McGrath
CEO and President, director

Sources

  1. SECBelenos Biosciences, Inc. filing history